Cohort Company News - MedTech Innovator

Osteoporosis Prevention Product Wins FDA Breakthrough Device Designation (featuring Bone Health Technologies)

DateDec 15 2020

Bone Health Technologies, creator of the OsteoBoost Vibration Belt that promises to reduce the risk of osteoporosis, has been granted “Breakthrough Device” designation by the US Food & Drug Administration. The FDA awards Breakthrough Device designation to products “that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human disease or conditions.”

Avelas Receives FDA Breakthrough Therapy Designation for Pegloprastide (AVB-620) for Use During Breast Cancer Surgery

DateDec 14 2020

Avelas Biosciences, Inc., pioneering the field of intraoperative fluorescent cancer imaging, today announced that the company has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for pegloprastide (AVB-620) for the intraoperative detection and visualization of positive margins during breast cancer surgery.

U.K. Invests $330M to Lead the World In Healthcare AI (featuring Kheiron Medical Technologies)

DateDec 10 2020

This first tranche of investment boasts companies at a range of stages, from minimum viable products to established companies ready to scale.

Smart Stethoscope Helps Monitor and Diagnose Respiratory Conditions: Interview with Helena Binetskaya, CEO of Healthy Networks

DateDec 09 2020

LungPass, an AI-powered Bluetooth stethoscope has been developed by Healthy Networks, a company based in Talinn, Estonia. The device can analyze sounds from the lungs and help to diagnose or monitor a variety of respiratory conditions, with an initial focus on pneumonia and COPD.

Day Zero Diagnostics Wins $300K NIH Grant to Refine HAI Outbreak Analysis Service

DateDec 09 2020

Infectious disease startup Day Zero Diagnostics last week received a $300,000 grant from the National Institutes of Health to further develop its nanopore sequencing-based technology for the analysis of healthcare-associated infection (HAI) outbreaks.

Conversations with Medtech Pioneers: MedTech Innovator’s 2020 Grand Prize Winner, Rhaeos

DateDec 08 2020

At Advamed’s Medtech Conference, the top 5 finalists pitched with the Grand Prize awarded to Rhaeos CEO, Anna Lisa Somera. Rhaeos has a novel wireless, wearable sensor for the monitoring of shunts in patients with Hydrocephalus.

Safety and Efficacy of Intermittent Colonic Exoperistalsis Device to Treat Chronic Constipation: A Prospective Multicentric Clinical Trial, featuring MOWOOT

DateDec 01 2020

MOWOOT automatically provides intermittent colonic exo-peristalsis (ICE) treatment like that in manual massage.

This Startup Is Changing Cancer Detection Around the World (featuring X-ZELL)

DateDec 01 2020

X-ZELL is developing an accurate, affordable, and globally scalable early cancer detection from 10mL blood samples, which is unprecedented.

Vectorious’ In-Heart Microcomputer Wins FDA Breakthrough Nod

DateNov 30 2020

The V-LAP system is the first digital, wireless, battery-free device that can communicate from deep within the body using high-resolution waveform morphology, according to the Tel Aviv-based startup.

First Use of nView’s Novel 3D Imaging Technology in Pediatric Spine Surgery

DateNov 24 2020

The innovation, insta-3D™ imaging from company nView medical, is designed to make 3D images available in the operating room quickly and safely. The 3D images provide surgeons with better visualization, allowing them to continue improving patient care and outcomes.

GT Medical Technologies Announces $16 Million Financing to Expand Availability of Targeted Therapy for Patients with Recurrent Brain Tumors

DateNov 23 2020

GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced it has raised $16 million in a Series B financing led by MVM Partners with participation from existing investors MedTech Venture Partners and BlueStone Venture Partners.

New Diabetes ‘CGKM’ Sensor Will Monitor Both Glucose and Ketones (featuring PercuSense)

DateNov 22 2020

Digital health startup PercuSense in Southern California — which has former Medtronic Diabetes engineering talent at its helm — is working on this next-generation tech for diabetes, a combined continuous glucose monitor (CGM) that also keeps tabs on ketones.

Explorer Surgical Launches Advanced Video for Remote Surgery

DateNov 22 2020

ExplORer Surgical, a Chicago-based startup that's developed an interactive platform for surgeons, has launched a new suite of advanced audio and video capabilities to make remote support easier in the operating room (OR).

Subtle Medical Raises $12.2 Million in Series A Funding to Expand Its AI Imaging Solutions

DateNov 19 2020

Subtle will use the funds to grow their product portfolio and support the global demand to make medical imaging faster and safer for all.

Medable raises $91M for Its Clinical Trial Management Software

DateNov 19 2020

The clinical trial management software developer Medable has raised $91 million in a new round of financing as life sciences companies struggle with how to conduct the necessary validation studies of new drugs and devices in a pandemically challenged environment.

Allotrope Medical Announces FDA Clearance of StimSite™

DateNov 17 2020

StimSite provides ob/gyns, general and colorectal surgeons the new ability to use their existing surgical instruments to help locate and identify ureters using electrical stimulation.

X-COR Therapeutics, an Alira Health Ventures Portfolio Company, Closes Initial $2.6M Funding Round.

DateNov 12 2020

Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, congratulates X-COR Therapeutics for closing a $2.6M seed financing to continue developing its novel extracorporeal carbon dioxide removal device toward clinical trials.

CoapTech Awarded $1.6M from NIH for Pediatric Feeding Tube Placement Device

DateNov 12 2020

Grant will support development and clinical evaluation of world’s first ultrasound-based gastrostomy device for pediatric patients.

Nanowear Receives FDA 510(k) Clearance for SimpleSENSE, a Cloth-Based Wearable Remote Diagnostic Monitoring Platform

DateNov 11 2020

Nanowear www.nanowearinc.com, the leading connected-care and remote diagnostic platform, today announced it has received FDA Class II 510(k) clearance for a first-of-its-kind cloth-based diagnostic platform, SimpleSENSE.

UCSF Rosenman Institute Announces Companies Chosen for “ADAPT” Program (featuring Vynca)

DateNov 10 2020

The UCSF Rosenman Institute announced today the startups selected in “UCSF Rosenman ADAPT,” a competitive global program for startup companies developing solutions to increase healthcare efficiency. Bold, ConsejoSano, EMME, GroupWell, Oshi, Vynca, and Woebot were selected for their innovative approaches and market promise.